The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA Compliance for Peptide Therapy and BPC 157 Holt Law Compounded "semaglutide" is not FDA approved semaglutide.com FDA's Overreach on Compounded Peptides